More... | Pharma Marketer

Garage Biotech

Friday, March 12th, 2010

Freeman Dyson has written about his belief that molecular biology is becoming a field where even basement tinkerers can accomplish things.

Posted in: In the Pipeline | 0 Comments »

Read the full story

The Daily Telegraph in the UK has a story today claiming that a 1951 outbreak of hallucinations and dementia in the French village of Pont-Saint-Esprit was not (as everyone thought ) an example of ergot poisoning.

Posted in: In the Pipeline | 0 Comments »

Read the full story

Intermune’s Rise

Thursday, March 11th, 2010

If you want to know why people continue to speculate in biotech stocks, just take a look at the stairsteppy last few days of trading in Intermune (ITMN). Last Thursday it was at $15; now it’s at $38. And all you have to do to cash in on these moves is read the FDA’s mind! That’s not a money-making proposition, in case anyone thinks I’m advocating it

Posted in: In the Pipeline | 0 Comments »

Read the full story

Vaccines in the Court

Wednesday, March 10th, 2010

The Supreme Court has agreed to hear a vaccine-liability case, in an attempt to untangle conflicting lower court rulings. This all turns on the 1986 act that shields manufacturers from liability suits and a followup law that establishes a separate compensation system for injuries

Posted in: In the Pipeline | 0 Comments »

Read the full story

How Not to Do It: Liquid Oxygen Cylinders

Wednesday, March 10th, 2010

We haven’t had a How Not to Do It around here in a while, so here’s a companion piece to the famous Sealed-Up Liquid Nitrogen Tank . This incident happened (as far as I can tell) about ten years ago. It’s been used in a number of safety presentations then, thanks to the Airgas Corp., whose safety officer assembled a number of photos (and this is the time to emphasize that they had nothing to do with the accident itself, because people who work for a pressurized-gas company actually know how to handle pressure vessels

Posted in: In the Pipeline | 0 Comments »

Read the full story

A GSK/Sirtris Wrap-Up

Tuesday, March 9th, 2010

Nature Biotechnology weighs in on the GSK/Sirtris controversy.

Posted in: In the Pipeline | 0 Comments »

Read the full story

Bad News at Exelixis

Monday, March 8th, 2010

I’m hearing from more than one source that Exelixis has laid off about 40% of their work force, which is somewhere around 250 people (the numbers I get don’t all agree).

Posted in: In the Pipeline | 0 Comments »

Read the full story

Not Gonna Make That One

Monday, March 8th, 2010

A discussion at work the other day got me to thinking: what structures do you medicinal chemists out there just refuse to work on?

Posted in: In the Pipeline | 0 Comments »

Read the full story

Merck/Schering-Plough People?

Friday, March 5th, 2010

Kim Girard, a reporter from CBS Interactive is doing a story on how people are coping with the merger – if you’d like to speak with her, she’s at (de-spammified): kim.berg30-at-gmail.com. I didn’t have any direct knowledge to help her, so I offered to post this to see if she gets something useful. .

Posted in: In the Pipeline | 0 Comments »

Read the full story